Patents by Inventor Raphael Nir

Raphael Nir has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS FOR THE PREVENTION AND TREATMENT OF DISEASES AND THE USE THEREOF
    Publication number: 20230132265
    Abstract: Aspects of the invention relate to novel synthetic compounds having binding affinity with galectin proteins.
    Type: Application
    Filed: June 8, 2022
    Publication date: April 27, 2023
    Inventors: Eliezer Zomer, Peter G. Traber, Raphael Nir, Sharon Shechter, Joseph M. Johnson, Ryan George
  • SELENOGALACTOSIDE COMPOUNDS FOR THE PREVENTION AND TREATMENT OF DISEASES ASSOCIATED WITH GALECTIN AND THE USE THEREOF
    Publication number: 20230127345
    Abstract: Aspects of the invention relate to novel synthetic compounds having a binding affinity with galectin proteins.
    Type: Application
    Filed: November 4, 2022
    Publication date: April 27, 2023
    Inventors: Sharon Shechter, Eliezer Zomer, Peter G. Traber, Raphael Nir, Joseph M. Johnson, Ryan George
  • Compounds for the Prevention and Treatment of Medical Disorders and Uses Thereof
    Publication number: 20230116370
    Abstract: Aspects of the invention relate to compounds, pharmaceutical compositions, methods for the manufacturing of compounds and methods for treatment of various disorders mediated at least in part by one or more galectins.
    Type: Application
    Filed: July 8, 2022
    Publication date: April 13, 2023
    Inventors: Raphael NIR, Eliezer ZOMER, Peter G. TRABER, Joseph M. JOHNSON, Ryan GEORGE, Sharon SHECHTER
  • Compounds for the prevention and treatment of medical disorders and uses thereof
    Patent number: 11583530
    Abstract: Aspects of the invention relate to compounds, pharmaceutical compositions, methods for the manufacturing of compounds and methods for treatment of various disorders mediated at least in part by one or more galectins.
    Type: Grant
    Filed: August 3, 2018
    Date of Patent: February 21, 2023
    Assignee: GALECTIN SCIENCES, LLC
    Inventors: Raphael Nir, Eliezer Zomer, Peter G. Traber, Joseph M. Johnson, Ryan George, Sharon Shechter
  • Compounds for the prevention and treatment of diseases and the use thereof
    Patent number: 11576924
    Abstract: Aspects of the invention relate to novel synthetic compounds having binding affinity with galectin proteins.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: February 14, 2023
    Assignee: GALECTIN SCIENCES, LLC
    Inventors: Eliezer Zomer, Peter G. Traber, Raphael Nir, Sharon Shechter, Joseph M. Johnson, Ryan George
  • Compounds for the Prevention and Treatment of Diseases and the Use Thereof
    Publication number: 20200155586
    Abstract: Aspects of the invention relate to novel synthetic compounds having binding affinity with galectin proteins.
    Type: Application
    Filed: May 11, 2018
    Publication date: May 21, 2020
    Inventors: Eliezer Zomer, Peter G. Traber, Raphael Nir, Sharon Shechter, Joseph M. Johnson, Ryan George
  • Compounds for the Prevention and Treatment of Medical Disorders and Uses Thereof
    Publication number: 20200147088
    Abstract: Aspects of the invention relate to compounds, pharmaceutical compositions, methods for the manufacturing of compounds and methods for treatment of various disorders mediated at least in part by one or more galectins.
    Type: Application
    Filed: August 3, 2018
    Publication date: May 14, 2020
    Inventors: Raphael Nir, Eliezer Zomer, Peter G. Traber, Joseph M. Johnson, Ryan George, Sharon Shechter
  • Compounds for the Treatment of Systemic Insulin Resistance Disorders and the Use Thereof
    Publication number: 20200061095
    Abstract: Aspects of the invention relate to novel synthetic compounds for treatment of metabolic diseases partially associated with systemic insulin resistance caused by Galectin proteins binding and inhibiting insulin and TGFb1 receptors causing physiological disturbances in the insulin pathways.
    Type: Application
    Filed: May 11, 2018
    Publication date: February 27, 2020
    Inventors: Peter G. Traber, Eliezer Zomer, Deirdre Slate, Joseph M. Johnson, Ryan George, Sharon Shechter, Raphael Nir
  • SELENOGALACTOSIDE COMPOUNDS FOR THE PREVENTION AND TREATMENT OF DISEASES ASSOCIATED WITH GALECTIN AND THE USE THEREOF
    Publication number: 20190367552
    Abstract: Aspects of the invention relate to novel synthetic compounds having a binding affinity with galectin proteins.
    Type: Application
    Filed: March 3, 2017
    Publication date: December 5, 2019
    Inventors: Sharon Shechter, Eliezer Zomer, Peter G. Traber, Raphael Nir, Joseph M. Johnson, Ryan George